[Antioxidants and ARMD]

Arch Soc Esp Oftalmol. 2007 Jul;82(7):397-8; author reply 398-400. doi: 10.4321/s0365-66912007000700003.

[Article in Spanish]

Authors

A García Layana, A Salinas Alamán, S Recalde Maestre, P Fernández Robredo

PMID: 17647114
DOI: 10.4321/s0365-66912007000700003

No abstract available

Publication types

Comment
Letter

MeSH terms

Antioxidants / therapeutic use*
Clinical Trials as Topic
Dietary Supplements
Drug Approval
Evidence-Based Medicine
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use
Lung Neoplasms / chemically induced
Macular Degeneration / prevention & control*
Risk Reduction Behavior
Spain
beta Carotene / adverse effects
beta Carotene / therapeutic use

Substances

Antioxidants
Hydroxymethylglutaryl-CoA Reductase Inhibitors
beta Carotene